The co-stimulatory molecule B7-H3 promotes the epithelialmesenchymal transition in colorectal cancer

Oncotarget

Volumn 7, Issue 22, 2016, Pages 31755-31771

  Jiang, Bo ^a   Zhang, Ting ^b   Liu, Fen ^b   Sun, Zhangzhang ^b   Shi, Hanping ^a   Hua, Dong ^b   Yang, Chen ^c  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b JIANGNAN UNIVERSITY   (China)

^c SUZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

B7 H3; Co stimulatory molecule; Colorectal cancer; Epithelial mesenchymal transition; Immune response; Immunity; Immunology and Microbiology Section; Metastasis

Indexed keywords

BETA CATENIN; CD133 ANTIGEN; GELATINASE A; GELATINASE B; HERMES ANTIGEN; MEMBRANE PROTEIN; NERVE CELL ADHESION MOLECULE; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN B7 H3; PROTEIN KINASE B; SMAD1 PROTEIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; B7 ANTIGEN; CADHERIN; CD276 PROTEIN, HUMAN; SMAD1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CACO 2 CELL LINE; CANCER STAGING; CANCER STEM CELL; CANCER TISSUE; CARCINOGENESIS; CELL MEMBRANE; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SW480 CELL LINE; TUMOR INVASION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CACO-2 CELL LINE; CELL MOTION; CELL PROLIFERATION; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; PHENOTYPE; RNA INTERFERENCE; TIME FACTOR; TUMOR VOLUME;

AGED; ANIMALS; B7 ANTIGENS; BIOMARKERS, TUMOR; CACO-2 CELLS; CADHERINS; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASTIC STEM CELLS; PHENOTYPE; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; TIME FACTORS; TRANSFECTION; TUMOR BURDEN;

EID: 84973541076     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9035     Document Type: Article

References (50)

1. Weitz J, Koch M, Debus J, Hohler T, Galle PR and Buchler MW. Colorectal cancer. Lancet. 2005; 365:153-165.
2. Binefa G, Rodriguez-Moranta F, Teule A and Medina- Hayas M. Colorectal cancer: from prevention to personalized medicine. World journal of gastroenterology. 2014; 20:6786-6808.
3. Talbot LJ, Bhattacharya SD and Kuo PC. Epithelialmesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies. International journal of biochemistry and molecular biology. 2012; 3:117-136.
4. Thompson EW and Haviv I. The social aspects of EMTMET plasticity. Nature medicine. 2011; 17:1048-1049.
5. Zeisberg M and Neilson EG. Biomarkers for epithelialmesenchymal transitions. The Journal of clinical investigation. 2009; 119:1429-1437.
6. De Wever O, Pauwels P, De Craene B, Sabbah M, Emami S, Redeuilh G, Gespach C, Bracke M and Berx G. Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochemistry and cell biology. 2008; 130:481-494.
7. Huang SG, Zhang LL, Niu Q, Xiang GM, Liu LL, Jiang DN, Liu F, Li Y and Pu X. Hypoxia promotes Epithelial- Mesenchymal transition of hepatocellular carcinoma cells via inducing GLIPR-2 expression. PloS one. 2013; 8:e77497.
8. Gonzalez DM and Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Science signaling. 2014; 7:re8.
9. Dyson JK and Rutter MD. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk? World journal of gastroenterology. 2012; 18:3839- 3848.
10. Landskron G, De la Fuente M, Thuwajit P, Thuwajit C and Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. Journal of immunology research. 2014; 2014:149185.
11. Saurer L and Mueller C. T cell-mediated immunoregulation in the gastrointestinal tract. Allergy. 2009; 64:505-519.
12. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH and Galon J. Effector memory T cells, early metastasis, and survival in colorectal cancer. The New England journal of medicine. 2005; 353:2654-2666.
13. Singh AK, Gaur P and Das SN. Natural killer T cell anergy, co-stimulatory molecules and immunotherapeutic interventions. Human immunology. 2014; 75:250-260.
14. Abdoli R and Najafian N. T Helper Cells Fate Mapping by Co-stimulatory Molecules and its Functions in Allograft Rejection and Tolerance. International journal of organ transplantation medicine. 2014; 5:97-110.
15. Ceeraz S, Nowak EC and Noelle RJ. B7 family checkpoint regulators in immune regulation and disease. Trends in immunology. 2013; 34:556-563.
16. Fernando RI, Castillo MD, Litzinger M, Hamilton DH and Palena C. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer research. 2011; 71:5296-5306.
17. Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K and Chen L. B7-H3: a costimulatory molecule for T cell activation and IFNgamma production. Nat Immunol. 2001; 2:269-274.
18. Dong C, Nurieva RI and Prasad DV. Immune regulation by novel costimulatory molecules. Immunol Res. 2003; 28:39- 48.
19. Sun M, Richards S, Prasad DV, Mai XM, Rudensky A and Dong C. Characterization of mouse and human B7-H3 genes. J Immunol. 2002; 168:6294-6297.
20. Dai W, Shen G, Qiu J, Zhao X and Gao Q. Aberrant expression of B7-H3 in gastric adenocarcinoma promotes cancer cell metastasis. Oncol Rep. 2014; 32:2086-2092.
21. Liu Y, Vlatkovic L, Saeter T, Servoll E, Waaler G, Nesland JM, Giercksky KE and Axcrona K. Is the clinical malignant phenotype of prostate cancer a result of a highly proliferative immune-evasive B7-H3-expressing cell population? Int J Urol. 2012.
22. Yamato I, Sho M, Nomi T, Akahori T, Shimada K, Hotta K, Kanehiro H, Konishi N, Yagita H and Nakajima Y. Clinical importance of B7-H3 expression in human pancreatic cancer. Br J Cancer. 2009; 101:1709-1716.
23. Baral A, Ye HX, Jiang PC, Yao Y and Mao Y. B7-H3 and B7-H1 expression in cerebral spinal fluid and tumor tissue correlates with the malignancy grade of glioma patients. Oncology letters. 2014; 8:1195-1201.
24. Sun J, Chen LJ, Zhang GB, Jiang JT, Zhu M, Tan Y, Wang HT, Lu BF and Zhang XG. Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma. Cancer Immunol Immunother. 2010; 59:1163-1171.
25. Xu L, Ding X, Tan H and Qian J. Correlation between B7- H3 expression and matrix metalloproteinases 2 expression in pancreatic cancer. Cancer cell international. 2013; 13:81.
26. Liu H, Tekle C, Chen YW, Kristian A, Zhao Y, Zhou M, Liu Z, Ding Y, Wang B, Maelandsmo GM, Nesland JM, Fodstad O and Tan M. B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation. Mol Cancer Ther. 2011; 10:960-971.
27. Zhao X, Zhang GB, Gan WJ, Xiong F, Li Z, Zhao H, Zhu DM, Zhang B, Zhang XG and Li DC. Silencing of B7-H3 increases gemcitabine sensitivity by promoting apoptosis in pancreatic carcinoma. Oncology letters. 2013; 5:805-812.
28. Zhang T, Jiang B, Zou ST, Liu F and Hua D. Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3. World J Gastroenterol. 2015; 21:1804- 1813.
29. Todosi AM, Gavrilescu MM, Anitei GM, Filip B and Scripcariu V. Colon cancer at the molecular level- usefulness of epithelial-mesenchymal transition analysis. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi. 2012; 116:1106-1111.
30. Ling V, Wu PW, Spaulding V, Kieleczawa J, Luxenberg D, Carreno BM and Collins M. Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss. Genomics. 2003; 82:365-377.
31. Steinberger P, Majdic O, Derdak SV, Pfistershammer K, Kirchberger S, Klauser C, Zlabinger G, Pickl WF, Stockl J and Knapp W. Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J Immunol. 2004; 172:2352-2359.
32. Ingebrigtsen VA, Boye K, Nesland JM, Nesbakken A, Flatmark K and Fodstad O. B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome. BMC Cancer. 2014; 14:602.
33. Hu Y, Lv X, Wu Y, Xu J, Wang L, Chen W, Zhang W, Li J, Zhang S and Qiu H. Expression of costimulatory molecule B7-H3 and its prognostic implications in human acute leukemia. Hematology. 2015; 20: 187-195.
34. Mao Y, Li W, Chen K, Xie Y, Liu Q, Yao M, Duan W, Zhou X, Liang R and Tao M. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer. Oncotarget. 2015; 6:3452-3461. doi: 10.18632/oncotarget.3097.
35. Ingebrigtsen VA, Boye K, Tekle C, Nesland JM, Flatmark K and Fodstad O. B7-H3 expression in colorectal cancer: Nuclear localization strongly predicts poor outcome in colon cancer. Int J Cancer. 2012; 131:2528-36.
36. Chen X, Bai Y, Cui W, Wang Z, Zhang G, Xu Y, Zhu X, Li Y and Wang JH. Effects of B7-H3 on the Inflammatory Response and Expression of MMP-9 in Mice with Pneumococcal Meningitis. J Mol Neurosci. 2013; 50:146- 53.
37. Wang L, Zhang Q, Chen W, Shan B, Ding Y, Zhang G, Cao N, Liu L and Zhang Y. B7-H3 is overexpressed in patients suffering osteosarcoma and associated with tumor aggressiveness and metastasis. PLoS One. 2013; 8:e70689.
38. Wang J, Chong KK, Nakamura Y, Nguyen L, Huang SK, Kuo C, Zhang W, Yu H, Morton DL and Hoon DS. B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma. J Invest Dermatol. 2013; 133:2050-2058.
39. Chen YW, Tekle C and Fodstad O. The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion. Curr Cancer Drug Targets. 2008; 8:404-413.
40. Tekle C, Nygren MK, Chen YW, Dybsjord I, Nesland JM, Maelandsmo GM and Fodstad O. B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes. Int J Cancer. 2012; 130:2282-2290.
41. Ghosh A, Pechota A, Coleman D, Upchurch GR, Jr. and Eliason JL. Cigarette smoke-induced MMP2 and MMP9 secretion from aortic vascular smooth cells is mediated via the Jak/Stat pathway. Human pathology. 2015; 46:284-294.
42. Sun KX, Xia HW and Xia RL. Anticancer effect of salidroside on colon cancer through inhibiting JAK2/ STAT3 signaling pathway. International journal of clinical and experimental pathology. 2015; 8:615-621.
43. Cao HH, Tse AK, Kwan HY, Yu H, Cheng CY, Su T, Fong WF and Yu ZL. Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling. Biochem Pharmacol. 2014; 87:424-434.
44. Liu F, Zhang T, Zou S, Jiang B and Hua D. B7H3 promotes cell migration and invasion through the Jak2/Stat3/MMP9 signaling pathway in colorectal cancer. Molecular medicine reports. 2015; 12:5455-5460.
45. Dawood S, Austin L and Cristofanilli M. Cancer stem cells: implications for cancer therapy. Oncology. 2014; 28:1101- 1107, 1110.
46. Cherciu I, Barbalan A, Pirici D, Margaritescu C and Saftoiu A. Stem cells, colorectal cancer and cancer stem cell markers correlations. Current health sciences journal. 2014; 40:153-161.
47. Zeineddine D, Hammoud AA, Mortada M and Boeuf H. The Oct4 protein: more than a magic stemness marker. American journal of stem cells. 2014; 3:74-82.
48. Bin Z, Guangbo Z, Yan G, Huan Z, Desheng L and Xueguang Z. Overexpression of B7-H3 in CD133+ colorectal cancer cells is associated with cancer progression and survival in human patients. The Journal of surgical research. 2014; 188:396-403.
49. Tsukamoto S, Mizuta T, Fujimoto M, Ohte S, Osawa K, Miyamoto A, Yoneyama K, Murata E, Machiya A, Jimi E, Kokabu S and Katagiri T. Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling. Scientific reports. 2014; 4:7596.
50. Zhang BY, Saijilafu, Liu CM, Wang RY, Zhu Q, Jiao Z and Zhou FQ. Akt-independent GSK3 inactivation downstream of PI3K signaling regulates mammalian axon regeneration. Biochemical and biophysical research communications. 2014; 443:743-748.